- Company Overview for BEAD BIOPHARMA LIMITED (SC763273)
- Filing history for BEAD BIOPHARMA LIMITED (SC763273)
- People for BEAD BIOPHARMA LIMITED (SC763273)
- More for BEAD BIOPHARMA LIMITED (SC763273)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
31 Oct 2024 | TM01 | Termination of appointment of Daniel Ozanne as a director on 31 October 2024 | |
18 Oct 2024 | AA | Total exemption full accounts made up to 31 March 2024 | |
19 Apr 2024 | AP01 | Appointment of Dr Daniel Ozanne as a director on 19 April 2024 | |
08 Apr 2024 | SH02 | Sub-division of shares on 2 April 2024 | |
03 Apr 2024 | MA | Memorandum and Articles of Association | |
03 Apr 2024 | RESOLUTIONS |
Resolutions
|
|
02 Apr 2024 | AP01 | Appointment of Mr Michael Sun as a director on 2 April 2024 | |
02 Apr 2024 | SH01 |
Statement of capital following an allotment of shares on 2 April 2024
|
|
25 Mar 2024 | CS01 | Confirmation statement made on 21 March 2024 with no updates | |
15 Dec 2023 | AD01 | Registered office address changed from 16 Seymour Avenue Dundee DD2 1HG Scotland to 6 Logie Mill Edinburgh EH7 4HG on 15 December 2023 | |
03 Nov 2023 | AD01 | Registered office address changed from Brook House 86 Brook Street Broughty Ferry Dundee DD5 1DQ Scotland to 16 Seymour Avenue Dundee DD2 1HG on 3 November 2023 | |
17 Jul 2023 | TM01 | Termination of appointment of Alan Michael Raymond as a director on 11 July 2023 | |
22 Mar 2023 | NEWINC |
Incorporation
Statement of capital on 2023-03-22
|